[HTML][HTML] North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension

JR Boike, BG Thornburg, SK Asrani, MB Fallon… - Clinical …, 2022 - Elsevier
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

The transjugular intrahepatic portosystemic shunt: an update

N Fidelman, SW Kwan, JM LaBerge… - American journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to review the indications, outcomes,
complications, patient selection, and technical aspects of creating a transjugular intrahepatic …

Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

A Shukla, A Shreshtha, A Mukund, C Bihari… - Hepatology …, 2021 - Springer
Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the
predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific …

Transjugular intrahepatic portosystemic shunt (TIPS): pathophysiologic basics, actual indications and results with review of the literature

H Strunk, M Marinova - RöFo-Fortschritte auf dem Gebiet der …, 2018 - thieme-connect.com
Hintergrund Der transjuguläre intrahepatische portosystemische Shunt (TIPS) ist eine nicht
operative Intervention zur Druckentlastung des Pfortadersystems. Technische …

Comprehensive review of TIPS technical complications and how to avoid them

RC Gaba, VL Khiatani, MG Knuttinen… - American Journal of …, 2011 - Am Roentgen Ray Soc
OBJECTIVE. The goal of this article is to describe potential technical complications related to
transjugular intrahepatic portosystemic shunts (TIPS) placement and to discuss strategies to …

Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome

G Hayek, M Ronot, A Plessier, A Sibert, M Abdel-Rehim… - Radiology, 2017 - pubs.rsna.org
Purpose To evaluate the long-term safety, technical success, and efficacy of transjugular
intrahepatic portosystemic shunt (TIPS) in a series of patients with Budd-Chiari syndrome …

Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis

G Mukhiya, X Zhou, X Han, D Jiao, G Pokhrel, Y Li… - Scientific Reports, 2022 - nature.com
This study was performed to evaluate the outcome of endovascular intervention therapy for
Budd-Chiari syndrome (BCS) and compare recanalization, transjugular intrahepatic …

Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome

M Vacca, C Degirolamo… - … Systems Biology and …, 2011 - Wiley Online Library
Metabolic syndrome (MS) is a cluster of different diseases, namely central obesity,
hypertension, hyperglycemia, and dyslipidemia, together with a pro‐thrombotic and pro …

Efficacy and safety of transjugular intrahepatic portosystemic shunt creation for Budd-Chiari syndrome: a systematic review and meta-analysis

S Giri, A Kale, A Shukla - Journal of Vascular and Interventional Radiology, 2022 - Elsevier
Purpose To assess the critical role of transjugular intrahepatic portosystemic shunt (TIPS) in
the management of Budd-Chiari syndrome (BCS), as the data with respect to the safety and …

Transjugular intrahepatic portosystemic shunt in the treatment of Budd–Chiari syndrome: a critical review of literatures

X Qi, M Yang, D Fan, G Han - Scandinavian journal of …, 2013 - Taylor & Francis
An increasing number of patients with Budd–Chiari syndrome (BCS) have undergone
transjugular intrahepatic portosystemic shunt (TIPS). However, the critical role of TIPS in the …